Pharmacological Treatment of Ascites: Challenges and Controversies

Pharmacological Treatment of Ascites: Challenges and Controversies

Ascites is the most common complication from cirrhosis related to portal hypertension and depicts the onset of hepatic decompensation. Ranging from uncomplicated to refractory ascites, the progression carries prognostic value by reflecting the deterioration of underlying cirrhosis and portal hyperte...

Full description

Saved in:
Bibliographic Details
Main Authors: Jimmy Che-To Lai, Junlong Dai, Lilian Yan Liang, Grace Lai-Hung Wong, Vincent Wai-Sun Wong, Terry Cheuk-Fung Yip
Format: Article
Language:English
Published: MDPI AG 2025-02-01
Series:Pharmaceuticals
Subjects:
cirrhosis
ascites
antiplatelet agents
anticoagulants
non-selective beta-blockers
albumin
Online Access:https://www.mdpi.com/1424-8247/18/3/339
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/1424-8247/18/3/339

Similar Items